News | November 13, 2025
The new company aims to transform cutting-edge, highly scalable technologies into innovative drug discovery platforms
A bio-analytical Remote Regulatory Assessment was also conducted from October 30 to November 7, 2025, and concluded with no observations
Orphan drug designation (ODD) by the USFDA for Desidustat, provides eligibility for a potential seven-year marketing exclusivity subject to the USFDA approval
PET sheets are widely recognised for their superior clarity, strength, and barrier properties
The new CMC Process R&D Center represents a strategic investment in scale, sustainability, and specialization
The product is indicated for the chronic management of patients with Urea Cycle Disorders
In this role, Neeraj will be responsible for crafting strategy, driving profitable growth through organic and inorganic models, expanding client base
Acquisition strengthens EY’s Veeva Centers of Excellence, expanding clinical, regulatory, and commercial services for global pharma and biotech companies
The new cGMP-compliant HPAPI Laboratory is equipped with state-of-the-art isolators designed to meet Occupational Exposure Band 5 (OEB-5) requirements
Subscribe To Our Newsletter & Stay Updated
